B.C.’s top health officials will provide an update on the latest infections of COVID-19 in the province on Tuesday, May 19 at 3 p.m. PT.
B.C. has recorded 16 new COVID-19 cases in the 48-hour period between Saturday and Monday, as the province prepares to enter Phase 2 of its pandemic response with a gradual reopening of businesses and services.
Speaking in a daily briefing on Monday, Provincial Health Officer Dr. Bonnie Henry said there have been two more deaths from the illness in the province.
Phase 2 of B.C.’s restart plan kicks off today and Henry says the latest guidelines for businesses that are allowed to begin reopening are now available on the province’s website.
Henry says each business must have a COVID-19 safety plan in place that customers, employees and public health officials may access.
B.C. reported 16 new cases of COVID-19 between Saturday and midday Monday, bringing the province’s total to 2,444.
Henry says 335 of those cases are active, with 47 people in hospital and 12 in critical or intensive care.
On Monday, it was announced that two more people have died after contracting the novel coronavirus, raising the province’s death toll to 143.
Henry says there are no new community outbreaks, but there are ongoing outbreaks in 14 long-term care facilities with one outbreak declared over at the Dufferin Care Centre in the Fraser health region.
To date, 1,966 people have recovered from the disease.
Henry warned that as the province begins to reopen, the potential for a flare-up does go up.
“For many the transition brings anticipation — but it also brings further apprehension and anxiety as schools and businesses look to open once again,” she said.
“We are still learning the new ways of safe social interactions and doing things we’ve never had to do before. And that itself can cause new anxiety and concern.”
READ MORE: How B.C. plans to ease COVID-19 restrictions
Top COVID-19 stories today
Health officials widely agree the most important thing you can do to prevent coronavirus and other illnesses is to wash your hands regularly and avoid touching your face.
The World Health Organization said more than 80 per cent of COVID-19 infections are estimated to be mild.
What’s happening elsewhere in Canada
As of Monday, there were 78,072 confirmed cases of COVID-19 in Canada.
The numbers are not a complete picture, as they don’t account for people who haven’t been tested, those being investigated as a potential case and people still waiting for test results.
For a look at what’s happening across the country and the world, check the CBC interactive case tracker.
What are the symptoms of COVID-19?
Common symptoms include:
But more serious symptoms can develop, including difficulty breathing and pneumonia.
What should I do if I feel sick?
Stay home. Isolate yourself and call your local public health authority or 811. Do not visit an emergency room or urgent care centre to get tested.
Non-medical information about COVID-19 is available in B.C. from 7:30 a.m.-8 p.m. PT, seven days a week at 1-888-COVID19 (1-888-268-4319).
What can I do to protect myself?
- Wash your hands frequently and thoroughly. Keep them clean.
- Keep at least two metres away from people who are sick.
- When outside the home, keep two metres away from other people.
- Avoid touching your eyes, nose and mouth.
- Masks won’t fully protect you from infection, but can help prevent you from infecting others.
More detailed information on the outbreak is available on the federal government’s website.
If you have a COVID-19-related story we should pursue that affects British Columbians, please email us at email@example.com
City asking people to wear masks on buses, but not mandatory – GuelphToday
As the city prepares to allow more riders on Guelph Transit buses, it is asking riders to wear a non-medical mask or face covering.
They are not mandatory.
Free 30-minute Guelph Transit service will continue for the rest of June but the city says thta with more businesses reopening and more people heading back to work, Guelph Transit is preparing to resume fare collection and regular schedules later in the summer.
In a news release Friday morning, the city said the request is based advice from Wellington-Dufferin-Guelph Public Health.
“According to health officials, wearing a homemade face covering/non-medical mask is not a substitute for physical distancing and hand washing. Wearing a mask has not been proven to protect the person wearing it, but it can help protect others around you,” the release said.
“As the buses get busy again, physical distancing may not always be possible. We’re asking riders to wear a non-medical mask or face covering to help prevent the spread of COVID-19,” says Robin Gerus, general manager of Guelph Transit.
Guelph Transit is encouraging face coverings, not requiring them.
“It’s becoming more common to wear a mask on public transit in other cities, but it’s new for Guelph. Some riders may not be aware of or understand the latest guidelines from health officials. Some may not have resources to purchase or make a mask, or they may have a medical reason for not wearing one,” added Gerus. Everyone is welcome to use Guelph Transit, and we’re asking people to protect and respect each other as ridership increases.”
Since March, Guelph Transit made the following adjustments to slow the spread of COVID-19:
- free 30-minute service allows passengers to avoid using the farebox and board from the rear door
- plastic barrier between the driver and passengers
- hand sanitizing stations and cleaning supplies for drivers
- no more than 10 people per bus
- blocked several seats to encourage physical distancing between passengers
To prevent the spread of COVID-19, the City and Guelph Transit encourage riders to continue following the latest advice from Wellington-Dufferin-Guelph Public Health:
- wash your hands regularly or use hand sanitizer
- stay at least two metres away from people you don’t live with
- when you can’t maintain physical distancing, wear a non-medical mask or face covering
WHO resumes hydroxychloroquine trial on Covid-19 patients – ITIJ
On May 25, WHO suspended the trial of the drug, which is usually used to treat malaria patients, after a study published in medical journal The Lancet found that Covid-19 hospitalised patients treated with hydroxychloroquine had a higher risk of death, as well as an increased frequency of irregular heartbeats, than those who weren’t treated with it.
However, WHO officials have since asserted that there is no evidence that the drug reduces the mortality in these patients, and the study has since been retracted over data concerns.
“The executive group received this recommendation and endorsed the continuation of all arms of solidarity trial including hydroxychloroquine,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press conference 3 June, adding that WHO planned to continue to monitor the safety of the therapeutics being tested in trials involving over 3,500 patients spanning over 35 countries.
“WHO is committed to accelerating the development of effective therapeutics, vaccines and diagnostics as part of our commitment to serving the world with science, solutions and solidarity,” Ghebreyesus said.
'Truly sorry': Scientists pull panned Lancet study of Trump-touted drug – National Post
NEW YORK/LONDON — An influential study that found hydroxychloroquine increased the risk of death in COVID-19 patients has been withdrawn a week after it led to major trials being halted, adding to confusion about a malaria drug championed by U.S. President Donald Trump.
The Lancet medical journal pulled the study after three of its authors retracted it, citing concerns about the quality and veracity of data in it. The World Health Organization (WHO) will resume its hydroxychloroquine trials after pausing them in the wake of the study. Dozens of other trials have resumed or are in process.
The three authors said Surgisphere, the company that provided the data, would not transfer the dataset for an independent review and they “can no longer vouch for the veracity of the primary data sources.”
The fourth author of the study, Dr. Sapan Desai, chief executive of Surgisphere, declined to comment on the retraction.
The Lancet said it “takes issues of scientific integrity extremely seriously” adding: “There are many outstanding questions about Surgisphere and the data that were allegedly included in this study.”
Another study in the New England Journal of Medicine (NEJM) that used Surgisphere data and shared the same lead author, Harvard Medical School Professor Mandeep Mehra, was retracted for the same reason.
The Lancet said reviews of Surgisphere’s research collaborations were urgently needed.
The race to understand and treat the new coronavirus causing the COVID-19 pandemic has accelerated the pace of research and peer-reviewed scientific journals are go-to sources of information for doctors, policymakers and lay people alike.
Chris Chambers, a professor of psychology and an expert at the UK Center for Open Science, said The Lancet and the NEJM – which he described as “ostensibly two of the world’s most prestigious medical journals” – should investigate how the studies got through peer review and editorial checks.
“The failure to resolve such basic concerns about the data” raises “serious questions about the standard of editing” and about the process of peer review, he said.
The Lancet did not immediately respond to a Reuters request for comment. The NEJM could not immediately be reached for comment.
The observational study published in The Lancet on May 22 said it looked at 96,000 hospitalized COVID-19 patients, some treated with the decades-old malaria drug. It claimed that those treated with hydroxychloroquine or the related chloroquine had higher risk of death and heart rhythm problems than patients who were not given the medicines.
“I did not do enough to ensure that the data source was appropriate for this use,” the study’s lead author, Professor Mehra, said in a statement. “For that, and for all the disruptions – both directly and indirectly – I am truly sorry.”
Many scientists voiced concern about the study, which had already been corrected last week because some location data was wrong. Nearly 150 doctors signed an open letter to The Lancet calling the article’s conclusions into question and asking to make public the peer review comments that preceded publication.
Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine said the retraction decision was “correct” but still left unanswered the question about whether hydroxychloroquine is effective in COVID-19.
“It remains the case that the results from randomized trials are necessary to draw reliable conclusions,” he said. (Reporting by Michael Erman, Peter Henderson, Kate Kelland and Josephine Mason Editing by Leslie Adler, Tom Brown, Giles Elgood and Carmel Crimmins)
TFC's Bradley on Trump: We have a president who is completely empty – TSN
Donald Trumps campaign team pulls ad featuring NASA astronauts after backlash – Republic World – Republic World
U.S. economy added 2.5 million jobs in May as states reopened from COVID-19 shutdowns – CBC.ca
- Sports16 hours ago
NBA Board of Governors approves competitive format to restart 2019-20 season with 22 teams returning to play – NBA CA
- Science22 hours ago
The Strawberry Moon Eclipse May Be Visible Over Metro Vancouver This Week – 604 Now
- Tech18 hours ago
Rumor: Alleged 2021 5.5-inch iPhone prototype shows notchless screen and USB-C port – 9to5Mac
- Tech23 hours ago
Successful investors are using big data and machine learning—now you can, too – Financial Post
- Media24 hours ago
Police Chief responds to controversy over social media posts – Quinte News
- News8 hours ago
Canadians living in China watch developments in Meng case closely – CTV News
- Economy7 hours ago
BoC eyeing supply, consumer demand for July economic outlook, deputy says – BNNBloomberg.ca
- Science3 hours ago
Full 'Strawberry' Moon coincides with a penumbral lunar eclipse tonight – Daily Mail